Erasca | IPO Presentation Deck | 46 slides · page 18 of 46
The slide uses a comparative experimental design to demonstrate the superior efficacy of ERAS-007 in a specific biological pathway.
Pitch deck · solution · present_solution · sparse density
Slide locked Sign in to view
Slide schematic 3/3
chart 1/1 source-note 1/1 title 1/1
Components 3
other source-note headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1